Bluegrass Community Research. Inc

Lexington, Kentucky 40515

0 studies enrolling now · 19 studies all time

What they study most

Ankylosing Spondylitis, Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Osteoarthritis, Pain, Psoriatic Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) — Running, not enrolling
• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy — Stopped early
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study — Stopped early
• Tanezumab in Osteoarthritis of the Knee — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis — Completed
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) — Completed
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) — Completed
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) — Completed
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
• GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy — Completed
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® — Completed
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors — Completed
• Abatacept Versus Adalimumab Head-to-Head — Completed